TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Yoga for Health-related Quality of Life in Adult Cancer: A Randomized Controlled Feasibility Trial
Brief Summary: A feasibility study to determine the appropriateness of yoga intervention to improve health-related quality of life in adult cancer patients.


Options:
A: Arm Label: Pre and postoperative exercise; Type: EXPERIMENTAL; Interventions: Other: Physical activity | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Physical activity; Assigned to Arm(s): Pre and postoperative exercise
B: Arm Label: Yoga Group A: Minimum Exposure; Type: EXPERIMENTAL; Interventions: Other: Yoga | Arm Label: Yoga Group B: Medium Exposure; Type: EXPERIMENTAL; Interventions: Other: Yoga | Arm Label: Yoga Group C: Maximum Exposure; Type: EXPERIMENTAL; Interventions: Other: Yoga | Intervention Type: OTHER; Name: Yoga; Assigned to Arm(s): Yoga Group A: Minimum Exposure, Yoga Group B: Medium Exposure, Yoga Group C: Maximum Exposure
C: Arm Label: Exercise; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Exercise; Assigned to Arm(s): Exercise
D: Arm Label: Stressmanagement counselling; Type: OTHER; Interventions: Other: Stressmanagement | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Stressmanagement; Assigned to Arm(s): Stressmanagement counselling

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Modifying Eating and Lifestyles at School (MEALS) Study
Brief Summary: The purpose of this study is to examine the impact of introducing healthier, chef-enhanced foods and/or environmental modifications (choice architecture) on selection and consumption of school foods among elementary and middle school students.


Options:
A: Arm Label: Sucrose; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Sucrose | Arm Label: Aspartame; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Aspartame | Intervention Type: DIETARY_SUPPLEMENT; Name: Sucrose; Assigned to Arm(s): Sucrose | Intervention Type: DIETARY_SUPPLEMENT; Name: Aspartame; Assigned to Arm(s): Aspartame
B: Arm Label: control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Chef; Type: EXPERIMENTAL; Interventions: Other: Chef-enhanced meals | Arm Label: choice architecture; Type: EXPERIMENTAL; Interventions: Behavioral: choice architecture | Arm Label: Chef and choice architecture; Type: EXPERIMENTAL; Interventions: Behavioral: choice architecture, Other: Chef-enhanced meals | Intervention Type: BEHAVIORAL; Name: choice architecture; Assigned to Arm(s): Chef and choice architecture, choice architecture | Intervention Type: OTHER; Name: Chef-enhanced meals; Assigned to Arm(s): Chef, Chef and choice architecture
C: Arm Label: liquid to liquid,; Type: EXPERIMENTAL; Interventions: Behavioral: liquid to liquid | Arm Label: liquid to solid,; Type: EXPERIMENTAL; Interventions: Behavioral: liquid to solid | Arm Label: solid to liquid; Type: EXPERIMENTAL; Interventions: Behavioral: solid to liquid | Arm Label: solid to solid; Type: EXPERIMENTAL; Interventions: Behavioral: solid to solid | Intervention Type: BEHAVIORAL; Name: liquid to liquid; Assigned to Arm(s): liquid to liquid, | Intervention Type: BEHAVIORAL; Name: liquid to solid; Assigned to Arm(s): liquid to solid, | Intervention Type: BEHAVIORAL; Name: solid to liquid; Assigned to Arm(s): solid to liquid | Intervention Type: BEHAVIORAL; Name: solid to solid; Assigned to Arm(s): solid to solid
D: Arm Label: Sugar-sweetened soft drink; Type: EXPERIMENTAL; Interventions: Other: Sugar-sweetened soft drink | Arm Label: Aspartame-sweetened soft drink; Type: EXPERIMENTAL; Interventions: Other: Aspartame-sweetened soft drink | Arm Label: Semi-skimmed milk; Type: ACTIVE_COMPARATOR; Interventions: Other: Semi-skimmed milk | Arm Label: Water; Type: PLACEBO_COMPARATOR; Interventions: Other: Water | Intervention Type: OTHER; Name: Sugar-sweetened soft drink; Assigned to Arm(s): Sugar-sweetened soft drink | Intervention Type: OTHER; Name: Aspartame-sweetened soft drink; Assigned to Arm(s): Aspartame-sweetened soft drink | Intervention Type: OTHER; Name: Semi-skimmed milk; Assigned to Arm(s): Semi-skimmed milk | Intervention Type: OTHER; Name: Water; Assigned to Arm(s): Water

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Modifying Eating and Lifestyles at School (MEALS) Study
Brief Summary: The purpose of this study is to examine the impact of introducing healthier, chef-enhanced foods and/or environmental modifications (choice architecture) on selection and consumption of school foods among elementary and middle school students.


Options:
A: Arm Label: control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Policy and Environmental Change; Type: EXPERIMENTAL; Interventions: Behavioral: Policy and Environmental Change | Intervention Type: BEHAVIORAL; Name: Policy and Environmental Change; Assigned to Arm(s): Policy and Environmental Change
B: Arm Label: control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Chef; Type: EXPERIMENTAL; Interventions: Other: Chef-enhanced meals | Arm Label: choice architecture; Type: EXPERIMENTAL; Interventions: Behavioral: choice architecture | Arm Label: Chef and choice architecture; Type: EXPERIMENTAL; Interventions: Behavioral: choice architecture, Other: Chef-enhanced meals | Intervention Type: BEHAVIORAL; Name: choice architecture; Assigned to Arm(s): Chef and choice architecture, choice architecture | Intervention Type: OTHER; Name: Chef-enhanced meals; Assigned to Arm(s): Chef, Chef and choice architecture
C: Arm Label: Order; Type: EXPERIMENTAL; Interventions: Behavioral: Order | Arm Label: Packaging; Type: EXPERIMENTAL; Interventions: Behavioral: Packaging | Arm Label: Pricing; Type: EXPERIMENTAL; Interventions: Behavioral: Pricing | Arm Label: Relative Proportions; Type: EXPERIMENTAL; Interventions: Behavioral: Relative Proportions | Arm Label: Default Option; Type: EXPERIMENTAL; Interventions: Behavioral: Default Option | Intervention Type: BEHAVIORAL; Name: Order; Assigned to Arm(s): Order | Intervention Type: BEHAVIORAL; Name: Packaging; Assigned to Arm(s): Packaging | Intervention Type: BEHAVIORAL; Name: Pricing; Assigned to Arm(s): Pricing | Intervention Type: BEHAVIORAL; Name: Relative Proportions; Assigned to Arm(s): Relative Proportions | Intervention Type: BEHAVIORAL; Name: Default Option; Assigned to Arm(s): Default Option
D: Arm Label: Variety Group; Type: EXPERIMENTAL; Interventions: Behavioral: Variety Group, Behavioral: Nutrition Education Control | Arm Label: Nutrition Education Control; Type: EXPERIMENTAL; Interventions: Behavioral: Nutrition Education Control | Intervention Type: BEHAVIORAL; Name: Variety Group; Assigned to Arm(s): Variety Group | Intervention Type: BEHAVIORAL; Name: Nutrition Education Control; Assigned to Arm(s): Nutrition Education Control, Variety Group

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Explanatory Clinical Trial of a Novel Parent Intervention for Childhood Anxiety (SPACE)
Brief Summary: Childhood anxiety disorders are very common, carry tremendous personal and societal costs, frequently do not respond adequately to treatment, and involving parents in treatment has so far not enhanced outcomes. Explanatory clinical trials are needed to identify parent specific mechanisms of change that are not targeted in direct child treatment, and to identify markers of who is most likely to benefit from parent intervention. This study is an explanatory clinical trial of a parent based intervention and of cognitive behavioral therapy, and an investigation of biological and behavioral moderators of treatment response.


Options:
A: Arm Label: Sertraline; Type: ACTIVE_COMPARATOR; Interventions: Drug: Sertraline (SRT) | Arm Label: CBT; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Cognitive Behavioral Therapy (CBT) | Arm Label: SRT + CBT; Type: ACTIVE_COMPARATOR; Interventions: Drug: Sertraline (SRT), Behavioral: Cognitive Behavioral Therapy (CBT) | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Sertraline (SRT); Assigned to Arm(s): SRT + CBT, Sertraline | Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Therapy (CBT); Assigned to Arm(s): CBT, SRT + CBT | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Active Treatment: CBT; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: CBT | Arm Label: Experimental Treatment: SPACE; Type: EXPERIMENTAL; Interventions: Behavioral: Parent-Based Treatment of Child and Adolescent Anxiety Disorders | Intervention Type: BEHAVIORAL; Name: Parent-Based Treatment of Child and Adolescent Anxiety Disorders; Assigned to Arm(s): Experimental Treatment: SPACE | Intervention Type: BEHAVIORAL; Name: CBT; Assigned to Arm(s): Active Treatment: CBT
C: Arm Label: 1. Cognitive Behavioral Therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Behavioral Therapy | Arm Label: 2. Client Centered Therapy; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Client Centered Therapy | Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Therapy; Assigned to Arm(s): 1. Cognitive Behavioral Therapy | Intervention Type: BEHAVIORAL; Name: Client Centered Therapy; Assigned to Arm(s): 2. Client Centered Therapy
D: Arm Label: Cognitive Behavioral Therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Behavioral Therapy | Arm Label: Treatment as usual; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Treatment As Usual | Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Therapy; Assigned to Arm(s): Cognitive Behavioral Therapy | Intervention Type: BEHAVIORAL; Name: Treatment As Usual; Assigned to Arm(s): Treatment as usual

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase 1, Within Cohort, Randomized, Double Blind, Third-party Open, Placebo-controlled, Single- And Multiple Dose Escalation, Parallel Group Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Pf-06700841 In Healthy Subjects And Subjects With Plaque Psoriasis And Bioavailability Of A Tablet Formulation Relative To Suspension Formulation And The Effect Of Food On A Tablet Formulation Of Pf-06700841
Brief Summary: The main purpose of the study is to determine if PF-06700841 is safe and well tolerated when administered to humans. A secondary purpose is to assess what the body does to PF-06700841 and to assess what PF-06700841 does to the body when given as single and multiple doses. The pharmacokinetic properties of different forms of PF-06700841 may be studied (tablet and solution/suspension forms).


Options:
A: Arm Label: Ixekizumab; Type: EXPERIMENTAL; Interventions: Drug: Ixekizumab, Drug: Placebo | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Ixekizumab, Drug: Placebo | Intervention Type: DRUG; Name: Ixekizumab; Assigned to Arm(s): Ixekizumab, Placebo | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Ixekizumab, Placebo
B: Arm Label: PF-06700841 Oral Solution/Suspension; Type: EXPERIMENTAL; Interventions: Drug: PF-06700841 oral solution/suspension | Arm Label: PF-06700841 Tablet; Type: EXPERIMENTAL; Interventions: Drug: PF-06700841 tablet | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: DRUG; Name: PF-06700841 oral solution/suspension; Assigned to Arm(s): PF-06700841 Oral Solution/Suspension | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: PF-06700841 tablet; Assigned to Arm(s): PF-06700841 Tablet
C: Arm Label: LAS41008; Type: EXPERIMENTAL; Interventions: Drug: LAS41008 | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: LASW1835; Type: ACTIVE_COMPARATOR; Interventions: Drug: LASW1835 | Intervention Type: DRUG; Name: LAS41008; Assigned to Arm(s): LAS41008 | Intervention Type: DRUG; Name: LASW1835; Assigned to Arm(s): LASW1835 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Secukinumab 150 mg; Type: EXPERIMENTAL; Interventions: Drug: Secukinumab 150mg | Arm Label: Secukinumab 300 mg; Type: EXPERIMENTAL; Interventions: Drug: Secukinumab 300mg | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Secukinumab 150mg; Assigned to Arm(s): Secukinumab 150 mg | Intervention Type: DRUG; Name: Secukinumab 300mg; Assigned to Arm(s): Secukinumab 300 mg

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase 2, Double-blind, Dose-finding, Placebo-controlled Study to Assess the Safety and Efficacy of a Single Oral Administration of OBE001 to Improve Embryo Implantation Following IVF or ICSI
Brief Summary: The primary objective of this study is to assess the increase in clinical pregnancy rate after administration of a range of single oral doses of OBE001, an oral oxytocin antagonist, compared to placebo.


Options:
A: Arm Label: Endometrial injury group; Type: EXPERIMENTAL; Interventions: Procedure: Endometrial injury | Arm Label: Control group; Type: SHAM_COMPARATOR; Interventions: Procedure: Control group | Intervention Type: PROCEDURE; Name: Endometrial injury; Assigned to Arm(s): Endometrial injury group | Intervention Type: PROCEDURE; Name: Control group; Assigned to Arm(s): Control group
B: Arm Label: OBE001 dose 1; Type: EXPERIMENTAL; Interventions: Drug: OBE001 dose 1 | Arm Label: OBE001 dose 2; Type: EXPERIMENTAL; Interventions: Drug: OBE001 dose 2 | Arm Label: OBE001 dose 3; Type: EXPERIMENTAL; Interventions: Drug: OBE001 dose 3 | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: OBE001 dose 1; Assigned to Arm(s): OBE001 dose 1 | Intervention Type: DRUG; Name: OBE001 dose 2; Assigned to Arm(s): OBE001 dose 2 | Intervention Type: DRUG; Name: OBE001 dose 3; Assigned to Arm(s): OBE001 dose 3 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: Nolasiban 900 mg; Type: EXPERIMENTAL; Interventions: Drug: Nolasiban 900mg | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Nolasiban 900mg; Assigned to Arm(s): Nolasiban 900 mg | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: local ingury; Type: ACTIVE_COMPARATOR; Interventions: Procedure: local injury | Arm Label: control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: local injury; Assigned to Arm(s): local ingury

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Improving Mental Health Through Integration With Primary Care in Rural Karnataka
Brief Summary: This cluster Randomized Controlled Trial was designed to implement and evaluate the effects of a multi-level intervention designed to integrate mental health treatment into rural primary health clinics in South India using a collaborative care model.


Options:
A: Arm Label: Healthy Living Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Healthy Living Intervention | Arm Label: Enhanced Standard Care Model; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Healthy Living Intervention | Intervention Type: BEHAVIORAL; Name: Healthy Living Intervention; Assigned to Arm(s): Enhanced Standard Care Model, Healthy Living Intervention
B: Arm Label: Psychosocial counselling + Enhanced usual care (EUC); Type: EXPERIMENTAL; Interventions: Behavioral: Psychosocial counselling, Other: Enhanced Usual Care | Arm Label: Enhanced Usual Care (EUC); Type: ACTIVE_COMPARATOR; Interventions: Other: Enhanced Usual Care | Intervention Type: BEHAVIORAL; Name: Psychosocial counselling; Assigned to Arm(s): Psychosocial counselling + Enhanced usual care (EUC) | Intervention Type: OTHER; Name: Enhanced Usual Care; Assigned to Arm(s): Enhanced Usual Care (EUC), Psychosocial counselling + Enhanced usual care (EUC)
C: Arm Label: Trauma-Focused Cognitive Behavioral Therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Trauma-Focused Cognitive Behavioral Therapy | Arm Label: Waiting List Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Trauma-Focused Cognitive Behavioral Therapy; Assigned to Arm(s): Trauma-Focused Cognitive Behavioral Therapy
D: Arm Label: SUUBI-MAKA; Type: EXPERIMENTAL; Interventions: Behavioral: Suubi-Maka ('Hope for Families') | Arm Label: Usual Care; Type: OTHER; Interventions: Other: Usual Care | Intervention Type: BEHAVIORAL; Name: Suubi-Maka ('Hope for Families'); Assigned to Arm(s): SUUBI-MAKA | Intervention Type: OTHER; Name: Usual Care; Assigned to Arm(s): Usual Care

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Point-of-care Versus Standard Coagulation Tests Versus Restrictive Strategy to Guide Transfusion in Chronic Liver Failure Patients Requiring Central Venous Line: Prospective Randomized Trial
Brief Summary: The aim of this study is to compare three different blood transfusion strategies for coagulopathy correction before central venous catheterization in patients with chronic liver failure (cirrhosis and/or chronic liver graft dysfunction) admitted in intensive care unit.


Options:
A: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Active; Type: ACTIVE_COMPARATOR; Interventions: Drug: Eltrombopag | Intervention Type: DRUG; Name: Eltrombopag; Assigned to Arm(s): Active | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Coagulogram-based protocol; Type: ACTIVE_COMPARATOR; Interventions: Other: Coagulogram-based protocol | Arm Label: Thromboelastometry-based protocol; Type: EXPERIMENTAL; Interventions: Other: Thromboelastometry-based protocol | Arm Label: Restrictive strategy; Type: EXPERIMENTAL; Interventions: Other: Restrictive strategy | Intervention Type: OTHER; Name: Coagulogram-based protocol; Assigned to Arm(s): Coagulogram-based protocol | Intervention Type: OTHER; Name: Thromboelastometry-based protocol; Assigned to Arm(s): Thromboelastometry-based protocol | Intervention Type: OTHER; Name: Restrictive strategy; Assigned to Arm(s): Restrictive strategy
C: Arm Label: 1:1:1 Blood Transfusion Ratio; Type: ACTIVE_COMPARATOR; Interventions: Biological: 1:1:1 Blood Transfusion Ratio | Arm Label: 1:1:2 Blood Transfusion Ratio; Type: ACTIVE_COMPARATOR; Interventions: Biological: 1:1:2 Blood Transfusion Ratio | Intervention Type: BIOLOGICAL; Name: 1:1:1 Blood Transfusion Ratio; Assigned to Arm(s): 1:1:1 Blood Transfusion Ratio | Intervention Type: BIOLOGICAL; Name: 1:1:2 Blood Transfusion Ratio; Assigned to Arm(s): 1:1:2 Blood Transfusion Ratio
D: Arm Label: Transfusion Algorithm; Type: OTHER; Interventions: Other: POC-based transfusion algorithm | Intervention Type: OTHER; Name: POC-based transfusion algorithm; Assigned to Arm(s): Transfusion Algorithm

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Improving Mental Health in First Time Parents - A Randomized Controlled Pilot Study
Brief Summary: In the present pilot study the feasibility and efficacy of Baby Triple P- an antenatal parent training- are investigated. Healthy becoming first time parents were randomly allocated to either the Baby Triple P parent-training group or a care as usual control group. It is expected that 78 couples of becoming first time parents are recruited. It is hypothesized that parents and their infants in the parent training group will show significantly less psychopathology / regulation problems and better partnership quality than participants in the control condition.


Options:
A: Arm Label: Mom Power Intervention Group; Type: EXPERIMENTAL; Interventions: Behavioral: Mom Power Intervention Group | Arm Label: Mom Power Attentional Control Group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Mom Power Attentional Control Group | Intervention Type: BEHAVIORAL; Name: Mom Power Intervention Group; Assigned to Arm(s): Mom Power Intervention Group | Intervention Type: BEHAVIORAL; Name: Mom Power Attentional Control Group; Assigned to Arm(s): Mom Power Attentional Control Group
B: Arm Label: Self Empowerment Groups; Type: EXPERIMENTAL; Interventions: Behavioral: Self Empowerment Groups, Behavioral: Financial Empowerment, Behavioral: Matched Savings | Arm Label: Financial Empowerment; Type: EXPERIMENTAL; Interventions: Behavioral: Financial Empowerment, Behavioral: Matched Savings | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Self Empowerment Groups; Assigned to Arm(s): Self Empowerment Groups | Intervention Type: BEHAVIORAL; Name: Financial Empowerment; Assigned to Arm(s): Financial Empowerment, Self Empowerment Groups | Intervention Type: BEHAVIORAL; Name: Matched Savings; Assigned to Arm(s): Financial Empowerment, Self Empowerment Groups
C: Arm Label: Baby Triple P parent training group; Type: EXPERIMENTAL; Interventions: Behavioral: Baby Triple P | Arm Label: Care as usual control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Baby Triple P; Assigned to Arm(s): Baby Triple P parent training group
D: Arm Label: Immediate e-NET Group; Type: EXPERIMENTAL; Interventions: Behavioral: e-Net for Parents of Neurodiverse Children | Arm Label: Wait List Control Group; Type: EXPERIMENTAL; Interventions: Behavioral: e-Net for Parents of Neurodiverse Children | Intervention Type: BEHAVIORAL; Name: e-Net for Parents of Neurodiverse Children; Assigned to Arm(s): Immediate e-NET Group, Wait List Control Group

Answer: C